TWi Biotechnology, Inc. (TPEX:6610)
Taiwan · Delayed Price · Currency is TWD 17.15
+0.05 (0.29%)
Nov 13, 2026, 1:58 PM CST
TWi Biotechnology Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
27
Market Cap
3.53B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 66.40M | 65.15M | 5,228.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| SYN-TECH Chem. & Pharm. | 1.30B |
| Medigen Biotechnology | 1.27B |
| Sagittarius Life Science | 467.69M |
| BioGend Therapeutics | 235.24M |
| Pharmosa Biopharm | 53.38M |
| Formosa Pharmaceuticals | 51.67M |
| Shine-On BioMedical | 50.62M |
| UnicoCell Biomed | 22.46M |